Dr. Murad Adnan Aburajab, MD

Dr. Aburajab practices at Ascension St. Vincent Hospital - Indianapolis in Indianapolis, Indiana, part of Ascension Health Alliance.

Dr. Aburajab's NPI, 1376750745, was assigned on May 16, 2007. Dr. Aburajab graduated from University of Jordan Faculty of Medicine in 2002. Dr. Aburajab's Indiana license number on file is 01079804A.

Dr. Aburajab's primary practice is Ascension St. Vincent Hospital - Indianapolis, at 2001 W 86th St, Indianapolis, IN 46260 in Marion County. The practice phone is (317) 338-7000.

Dr. Aburajab's primary practice is Ascension St. Vincent Hospital - Indianapolis in Indianapolis, Indiana, part of Ascension Health Alliance. Dr. Aburajab is also affiliated with Hendricks Regional Health Danville Hospital. The medical group on file is Ascension Medical Group St Vincent. Dmand AI also links Dr. Aburajab to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aburajab practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Aburajab's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Aburajab is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Aburajab's licenses on file in 5 states: Indiana, Wisconsin, California, Iowa and Massachusetts.

Dmand AI lists acid reflux, acute gastroduodenitis, cirrhosis of the liver, colonoscopy, gastroenteritis, gastrointestinal bleeding, gastrointestinal inflammation and intestinal or bowel obstruction among the conditions Dr. Aburajab treats.

CMS data shows 935 Medicare services from Dr. Aburajab across 18 procedure codes in 2024, for 414 Medicare patients. Medicare paid $82,566 for them.

CMS counts 414 Medicare patients who saw Dr. Aburajab in 2024. The largest group is 65 to 74, with 174 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aburajab's median patient age at 68, with 54% women.

In 2024, Dr. Aburajab wrote 591 Medicare Part D claims for 192 patients. 85% of them were for generic drugs. CMS names the drug for 490 of them, across 13 drugs with 11 or more claims each, at $81,606 in total drug cost. In 2023, CMS named 403 claims across 10 drugs.

Dr. Aburajab accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 516 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Aburajab, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Aburajab, published from 2016 to 2018. 2017 was the busiest year, with 3. The most frequent topics are Cholangiopancreatography, Endoscopic Retrograde, Endoscopy, Digestive System and Stents. Dr. Aburajab's most frequent co-authors are Kulwinder S. Dua, MD, Abdul Haq Khan, MD and Zachary Lee Smith, MD.

CMS Open Payments shows 96 general payments to Dr. Aburajab from 27 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 54% of the total. Abbvie Inc. paid the most, $14,183.

Dr. Aburajab graduated from University of Jordan Faculty of Medicine in 2002.

Dr. Aburajab is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.